SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-11-063210
Filing Date
2011-11-10
Accepted
2011-11-10 16:13:59
Documents
2
Period of Report
2011-11-10

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 13077
2 EX-24 ex-24.htm EX-24 8183
  Complete submission text file 0001104659-11-063210.txt   22637
Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010
Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555
NEWLINK GENETICS CORP (Issuer) CIK: 0001126234 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEWLINK GENETICS CORP. 2503 SOUTH LOOP DR., SUITE 5100 AIMES IA 50010
Business Address
Lundquist David J. (Reporting) CIK: 0001512133 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35342 | Film No.: 111195569